GlaxoSmithKline

GlaxoSmithKline logo
🇬🇧United Kingdom
Ownership
Public
Established
1929-01-01
Employees
70.2K
Market Cap
$90B
Website
http://www.gsk.com
Introduction

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general med...

Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer

First Posted Date
2003-05-28
Last Posted Date
2017-06-09
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
75
Registration Number
NCT00061308
Locations
🇨🇦

GSK Investigational Site, Toronto, Ontario, Canada

Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension

Phase 4
Completed
Conditions
First Posted Date
2003-05-16
Last Posted Date
2015-04-14
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
501
Registration Number
NCT00060931
Locations
🇺🇸

GSK Investigational Site, Springfield, Virginia, United States

Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And Hypertension

Phase 4
Completed
Conditions
First Posted Date
2003-05-16
Last Posted Date
2015-04-15
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
1210
Registration Number
NCT00060918
Locations
🇺🇸

GSK Investigational Site, Milwaukee, Wisconsin, United States

A Dose-escalation Vaccine Trial in HER2-overexpressing Patients With High-risk Breast Cancer

First Posted Date
2003-04-09
Last Posted Date
2017-05-15
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
61
Registration Number
NCT00058526
Locations
🇮🇹

GSK Investigational Site, Perugia, Umbria, Italy

HerpeVac Trial for Young Women

First Posted Date
2003-04-01
Last Posted Date
2018-08-27
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
8323
Registration Number
NCT00057330
Locations
🇨🇦

GSK Investigational Site, Sherbrooke, Quebec, Canada

An 8 Week Depression Study In Adults Diagnosed With Major Depressive Disorder

Phase 2
Completed
Conditions
First Posted Date
2003-03-28
Last Posted Date
2010-10-04
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
546
Registration Number
NCT00057239
Locations
🇺🇸

GSK Investigational Site, Brown Deer, Wisconsin, United States

An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder

Phase 2
Completed
Conditions
First Posted Date
2003-03-28
Last Posted Date
2015-04-16
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
365
Registration Number
NCT00057226
Locations
🇺🇸

GSK Investigational Site, Bellevue, Washington, United States

An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder

Phase 2
Completed
Conditions
First Posted Date
2003-03-28
Last Posted Date
2015-04-16
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
367
Registration Number
NCT00057213
Locations
🇺🇸

GSK Investigational Site, Salt Lake City, Utah, United States

"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk

Phase 3
Completed
Conditions
Interventions
First Posted Date
2003-03-13
Last Posted Date
2016-09-23
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
8231
Registration Number
NCT00056407
Locations

GSK Investigational Site

Bipolar Disorder Study for Men and Women

Phase 3
Completed
Conditions
Interventions
First Posted Date
2003-03-11
Last Posted Date
2017-04-07
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
150
Registration Number
NCT00056277
Locations
🇺🇸

GSK Investigational Site, Brown Deer, Wisconsin, United States

© Copyright 2024. All Rights Reserved by MedPath